Bain & Company examines the macroeconomic challenges that have exacted a toll on healthcare buyouts, but predicts that the green shoots in deal activity will begin to reflect the industry’s strong fundamentals.
Read more here.
26 January 2024
Bain & Company examines the macroeconomic challenges that have exacted a toll on healthcare buyouts, but predicts that the green shoots in deal activity will begin to reflect the industry’s strong fundamentals.
Read more here.
You’ll be able to unsubscribe at any time.